prednisolone has been researched along with Neuroleptic Malignant Syndrome in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The case of a young female patient with neuroleptic malignant syndrome (NMS) and extended MRI white matter hyperintensity in the left parietal and both occipital lobes is reported." | 1.28 | MRI white matter hyperintensity in neuroleptic malignant syndrome (NMS)--a clue to pathogenesis? ( Becker, T; Beckmann, H; Hofmann, E; Kornhuber, J; Rupprecht, C; Weller, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, T | 1 |
| Kornhuber, J | 1 |
| Hofmann, E | 1 |
| Weller, M | 1 |
| Rupprecht, C | 1 |
| Beckmann, H | 1 |
1 other study available for prednisolone and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
MRI white matter hyperintensity in neuroleptic malignant syndrome (NMS)--a clue to pathogenesis?
Topics: Adult; Brain; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Neuroleptic Malig | 1992 |